Skip to search formSkip to main contentSkip to account menu

ansamitocin P 3

Known as: Ansamitomicin P-3, Maytansine, 3-o-de(2-(acetylmethylamino)-1-oxopropyl)-3-o-(1-oxobutyl)- 
An ansamacrolide and maytansine analogue originally isolated from the Ethiopian shrub Maytenus serrata with antineoplastic activity. Ansamitomicin P… 
National Institutes of Health

Related topics

Related topics

3 relations
Microtubule ProcessNCIt Antineoplastic Agent Terminology

Broader (1)

ansamitocins

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Rational approach to improve ansamitocin P‐3 production by integrating pathway engineering and substrate feeding in Actinosynnema pretiosum
Ansamitocin P‐3 (AP‐3) produced by Actinosynnema pretiosum is an important antitumor agent for cancer treatment, but its market… 
2013
2013
Enhancement of ansamitocin P-3 production in Actinosynnema pretiosum by a synergistic effect of glycerol and glucose
Ansamitocin P-3 (AP-3), a secondary metabolite produced by Actinosynnema pretiosum, is well known for its extraordinary antitumor… 
2007
2007
Chemoenzymatic approaches toward dechloroansamitocin P-3.
[reaction: see text] The enantioselective total synthesis of proansamitocin, a key biosynthetic intermediate of the highly potent… 
2006
2006
Construction of asm2 Deletion Mutant of Actinosynnema pretiosum and Medium Optimization for Ansamitocin P-3 Production Using Statistical Approach
Ansamitocin P-3 is a potent antitumor agent produced by A. pretiosum. A deletion mutant of A. pretiosum was constructed by… 
2005
2005
Metabolism studies of the anti-tumor agent maytansine and its analog ansamitocin P-3 using liquid chromatography/tandem mass spectrometry.
Maytansine, a potent clinically evaluated plant-derived anti-tumor drug, and its microbial counterpart, ansamitocin P-3, showed a… 
2005
2005
Statistical Approach to Development of Culture Medium for Ansamitocin P-3 Production with Actinosynnema pretiosum ATCC 31565
The Plackett-Burman design and the response surface method (RSM) with a central composite design (CCD) were employed to develop a… 
1984
1984
Chemical modification of ansamitocins. II. Synthesis of 3-epimaytansionoids via 3-maytansinones.
As part of our recent search for new semisynthetic analogs of maytansinoids having a better therapeutic ratio than maytansine, we… 
1982
1982
Biosynthetic origin of aminobenzenoid nucleus (C7N-unit) of ansamitocin, a group of novel maytansinoid antibiotics.
Recently, GHISALBA et al.2,3) showed that the aminobenzenoid nucleus of rifamycin produced by Nocardia mediterranei was derived… 
1981
1981
Hydroxylation of ansamitocin P-3.
Ansamitocin P-3 was converted into 15-hydroxyansamitocin P-3 (PHO-3), C32H43ClN2010, and 15-epi-15-hydroxyansamitocin P-3 (epi… 
1981
1981
Demethylation of ansamitocins and related compounds.
Ansamitocins were converted into 20-O-demethyl derivatives by bacteria. The structures of these products were elucidated from… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)